Nasal Corticosteroids prior authorization
Customize your policy alerts
Sign up for all careoregon policy alerts
Know when careoregon releases new policies or updates existing guidance.
Monitor payer policy activity
Prior authorization guideline governing coverage and authorization requirements for nasal corticosteroid products (example: flunisolide) for CareOregon members.
No material clinical or coverage changes in this revision.
Coverage criteria for nasal corticosteroids
Flunisolide initial approval
Covered when ALL of the following are met
Approval Length: Lifetime; Guideline Type: Step Therapy
Provider requirements, prior authorization and step therapy
Prior authorization required; step therapy applies
Prior authorization is required for flunisolide and is governed by step-therapy rules; approval requires evidence of a paid claim showing the member has filled any asthma medication in the last 365 days.
Step therapy requirement for flunisolide
Flunisolide is subject to the policy's Step Therapy guideline and will only be authorized when the specified approval criteria (including recent asthma medication fill) are met.
Document paid claim of recent asthma medication
The provider must document a paid pharmacy claim demonstrating the member filled any asthma medication within the prior 365 days to meet the approval criteria for flunisolide.
- Acceptable documentation: paid pharmacy claim records showing a fill date within the last 365 days.
Risk of denial without proof of recent asthma medication
If the provider does not provide paid-claim evidence that the member filled any asthma medication in the last 365 days, the request for flunisolide may be denied.
Background and clinical context
Nasal corticosteroids are commonly used to treat allergic and non-allergic rhinitis and related nasal inflammation. This guideline references flunisolide and ties authorization to evidence of recent asthma medication use, reflecting consideration of comorbid respiratory disease management.
For flunisolide, this policy applies a Step Therapy approach and requires documentation demonstrating the member has filled any asthma medication within the prior 365 days. Approval is set as Lifetime when the specified criteria are met.
Policy terms and definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.